Saskatchewan says multiple sclerosis liberation therapy clinical trial cancelled

REGINA – The Saskatchewan government says a clinical trial for the so-called liberation treatment for multiple sclerosis has been cancelled.

The province says it’s been told by a medical centre in Albany, N.Y., that it isn’t going ahead with the therapy that involves opening blocked neck veins.

Saskatchewan had planned to put up $2.2 million to have 86 patients from the province take part in the trial.

But the trial lead, Dr. Gary Siskin, has indicated that the research team couldn’t recruit enough participants to meet United States government requirements for a clinical trial.

Health Minister Dustin Duncan says the news is disappointing for some 3,500 Saskatchewan people who want to know whether the treatment can help relieve MS symptoms.

The Ministry of Health says it will explore other options.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community?

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.